AAMU
XENT

Amundi Asset Management US’s Intersect ENT, Inc XENT Stock Holding History

Amundi Asset Management US’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-120,000
Closed -$3.38K – 1700
2018
Q4 		$3.38K Buy
+120,000
New +$3.51M ﹤0.01% 932

Other funds holding XENT

HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Amundi Asset Management US's XENT Position: Q1 2019 in Review

Amundi Asset Management US sold out of Intersect ENT, Inc (XENT) in Q1 2019, closing a stake of 120,000 shares — an estimated $3.38K sold.

Amundi Asset Management US first reported a position in XENT in Q4 2018 and held it in 1 quarter. The position peaked at $3.38K in Q4 2018. 136 funds tracked by Wall St. Rank hold XENT as of Q1 2019.

  • Amundi Asset Management US reported no remaining Intersect ENT, Inc position as of Q1 2019 after selling out during the quarter.
  • Amundi Asset Management US sold 120,000 Intersect ENT, Inc shares in Q1 2019, an estimated $3.38K.
  • Amundi Asset Management US first reported a position in Intersect ENT, Inc in Q4 2018 and held it in 1 quarter.
  • Amundi Asset Management US's Intersect ENT, Inc position peaked at $3.38K in Q4 2018.
  • 136 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2019.

Based on Amundi Asset Management US's 13F filing for Q1 2019, filed 13 May 2019.